Skip to main content Accessibility help
×
Home

Injectional anthrax at a Scottish district general hospital

  • D. J. INVERARITY (a1), V. M. FORRESTER (a2), J. G. R. CUMMING (a3), P. J. PATERSON (a4), R. J. CAMPBELL (a5), T. J. G. BROOKS (a6), G. L. CARSON (a6) and J. P. RUDDY (a2)...

Summary

This retrospective, descriptive case-series reviews the clinical presentations and significant laboratory findings of patients diagnosed with and treated for injectional anthrax (IA) since December 2009 at Monklands Hospital in Central Scotland and represents the largest series of IA cases to be described from a single location. Twenty-one patients who fulfilled National Anthrax Control Team standardized case definitions of confirmed, probable or possible IA are reported. All cases survived and none required limb amputation in contrast to an overall mortality of 28% being experienced for this condition in Scotland. We document the spectrum of presentations of soft tissue infection ranging from mild cases which were managed predominantly with oral antibiotics to severe cases with significant oedema, organ failure and coagulopathy. We describe the surgical management, intensive care management and antibiotic management including the first description of daptomycin being used to treat human anthrax. It is noted that some people who had injected heroin infected with Bacillus anthracis did not develop evidence of IA. Also highlighted are biochemical and haematological parameters which proved useful in identifying deteriorating patients who required greater levels of support and surgical debridement.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Injectional anthrax at a Scottish district general hospital
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Injectional anthrax at a Scottish district general hospital
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Injectional anthrax at a Scottish district general hospital
      Available formats
      ×

Copyright

Corresponding author

* Author for correspondence: Dr D. J. Inverarity, Consultant Microbiologist, Monklands Hospital, Monkscourt Avenue, Airdrie ML6 OJS, Scotland, UK. (Email: Donald.Inverarity@nhs.net)

References

Hide All
1. McLauchlin, J, et al. An investigation into the microflora of heroin. Journal of Medical Microbiology 2002; 51: 10011008.
2. Ringertz, SH, et al. Injectional anthrax in a heroin skin-popper. Lancet 2000; 356: 15741575.
3. National Anthrax Outbreak Control Team. An outbreak of anthrax among drug users in Scotland, December 2009 to December 2010. Health Protection Scotland, 2011.
4. Health, Protection Scotland. NHS Lanarkshire alert on anthrax and heroin use. HPS Weekly Report 2012; 46: 261.
5. Jallali, N, et al. The surgical management of injectional anthrax. Journal of Plastic Reconstructive and Aesthetic Surgery 2010; 64: 276277.
6. Parcell, BJ, et al. Injection anthrax causing compartment syndrome and necrotising fasciitis. Journal of Clinical Pathology 2011; 64: 9596.
7. Powell, AGMT, et al. A case of septicaemic anthrax in an intravenous drug user. BMC Infectious Diseases 2011; 11: 21.
8. Johns, N, et al. An unusual case of peritonitis in an intravenous drug user. Gastroenterology 2011; 141: 435436.
9. Beaumont, G. Anthrax in a Scottish intravenous drug user. Journal of Forensic and Legal Medicine 2010; 17: 443445.
10. Bannard-Smith, J, et al. Anthrax infection in an intravenous drug user. Intensive Care Medicine 2013; 39: 530.
11. Radun, D, et al. Preliminary case report of fatal anthrax in an injecting drug user in North-Rhine-Westphalia, Germany, December 2009. Eurosurveillance 2010; 15: 14.
12. Meghji, S, Judd, O, Carr, E. Fatal cutaneous anthrax in a heroin user. Journal of Laryngology and Otology 2013; 127: 423425.
13. Grunow, R, et al. Injection anthrax – a new outbreak in heroin users. Deutsches Ärzteblatt International 2012; 109: 843848.
14. Knox, D, et al. Subcutaneous anthrax in three intravenous drug users: a new clinical diagnosis. Bone & Joint Journal 2011; 93: 414417.
15. Booth, MG, et al. Anthrax infection in drug users. Lancet 2010; 375: 13451346.
16. Sweeney, DA, et al. Anthrax infection. American Journal of Respiratory and Critical Care Medicine 2011; 184: 13331341.
17. Hicks, CW, et al. An overview of anthrax infection including the recently identified form of disease in injection drug users. Intensive Care Medicine 2012; 38: 10921104.
18. Brentall, CG. The medical treatment of anthrax. Lancet 1930; 216: 11741177.
19. Holzmann, T, et al. Fatal anthrax infection in a heroin user from southern Germany, June 2012. Eurosurveillance 2012; 17: 2012.
20. Hart, CA, Beeching, NJ. Prophylactic treatment of anthrax with antibiotics. British Medical Journal 2001; 323: 10171018.
21. Mallon, E, McKee, PH. Extraordinary case report: cutaneous anthrax. American Journal of Dermatopathology 1997; 19: 7982.
22. Health Protection Scotland. Clinical algorithm, clinical evaluation and management of drug users with possible anthrax, 2010 (http://www.documents.hps.scot.nhs.uk/giz/anthrax-outbreak/clinical-algorithm-part-of-clinical-guidance-v12-17032010-asv.pdf). Accessed 21 April 2014.
23. Brett, MM, et al. Soft tissue infections caused by spore-forming bacteria in injecting drug users in the United Kingdom. Epidemiology & Infection 2005; 133: 575582.
24. McGuigan, CC, et al. Lethal outbreak of infection with Clostridium novyi type A and other spore-forming organisms in Scottish injecting drug users. Journal of Medical Microbiology 2002; 51: 971977.
25. McLauchlin, J, et al. Amplified fragment length polymorphism (AFLP) analysis of Clostridium novyi, C. perfringens and Bacillus cereus isolated from injecting drug users during 2000. Journal of Medical Microbiology 2002; 51: 9901000.
26. Health Protection Scotland. Interim clinical guidance for the management of suspected anthrax in drug users, 2010 (http://www.documents.hps.scot.nhs.uk/giz/anthrax-outbreak/clinical-guidance-for-use-of-anthrax-immune-globulin-v12-1-2010-03-19.pdf). Accessed 4 April 2014.
27. Brook, I, et al. Clindamycin and quinolone therapy for Bacillus anthracis Sterne infection in 60Co-gamma-photon-irradiated and sham-irradiated mice. Journal of Antimicrobial Chemotherapy 2005; 56: 10741080.
28. Seaton, RA. Daptomycin: rationale and role in the management of skin and soft tissue infections. Journal of Antimicrobial Chemotherapy 2008; 62 (Suppl. 3): iii15iii23.
29. Heine, HS, et al. Efficacy of daptomycin against Bacillus anthracis in murine model of anthrax spore inhalation. Antimicrobial Agents & Chemotherapy 2010; 54: 44714473.
30. Wiedemann, B. Test results: characterising the antimicrobial activity of daptomycin. Clinical Microbiology & Infection 2006; 12 (Suppl. 8): 914.
31. Artenstein, AW, et al. Novel approaches to the treatment of systemic anthrax. Clinical Infectious Diseases 2012; 54: 11481161.
32. Hicks, CW, et al. The potential contributions of lethal and edema toxins to the pathogenesis of anthrax associated shock. Toxins 2011; 3: 11851202.
33. Moayeri, M, Leppla, SH. Cellular and systemic effects of anthrax toxin and edema toxin. Molecular Aspects of Medicine 2009; 30: 439455.
34. Sweeney, DA, et al. Anthrax lethal and edema toxin produce different patterns of cardiovascular and renal dysfunction and synergistically decrease survival in canines. Journal of Infectious Diseases 2010; 202: 18851896.
35. Kuehnert, MJ, et al. Clinical features that discriminate inhalational anthrax from other acute respiratory illnesses. Clinical Infectious Diseases 2003; 36: 328336.
36. Wall, DB, et al. Objective criteria may assist in distinguishing necrotizing fasciitis from nonnecrotizing soft tissue infection. American Journal of Surgery 2000; 179:1721.
37. Booth, M, et al. Comparison of survivors and nonsurvivors in 27 confirmed injectional anthrax cases from the 2009 outbreak in Scotland. Critical Care 2013; 17 (Suppl. 2): S26.
38. Shuetz, P, Albrich, W, Mueller, B. Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future. BMC Medicine 2011; 9: 107.
39. Baldari, CT, et al. Anthrax toxins: a paradigm of bacterial immune suppression. Trends in Immunology 2006; 27: 434440.

Keywords

Injectional anthrax at a Scottish district general hospital

  • D. J. INVERARITY (a1), V. M. FORRESTER (a2), J. G. R. CUMMING (a3), P. J. PATERSON (a4), R. J. CAMPBELL (a5), T. J. G. BROOKS (a6), G. L. CARSON (a6) and J. P. RUDDY (a2)...

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed